Invention Grant
- Patent Title: CXCR3 receptor antagonists
- Patent Title (中): CXCR3受体拮抗剂
-
Application No.: US13520234Application Date: 2011-01-05
-
Publication No.: US08952004B2Publication Date: 2015-02-10
- Inventor: John David Ginn , Ronald John Sorcek , Michael Robert Turner , Di Wu , Frank Wu
- Applicant: John David Ginn , Ronald John Sorcek , Michael Robert Turner , Di Wu , Frank Wu
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- International Application: PCT/US2011/020191 WO 20110105
- International Announcement: WO2011/084985 WO 20110714
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K31/541 ; A61K31/55 ; A61K31/551 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D498/08 ; C07D407/14 ; C07D211/26 ; C07D211/32 ; C07D213/74 ; C07D401/06 ; C07D401/12 ; C07D417/06 ; C07D417/12 ; C07D487/06 ; C07D497/04 ; A61K31/553 ; C07D413/06
Abstract:
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1 to R3, A, B, X, and n are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
Public/Granted literature
- US20130029971A1 CXCR3 RECEPTOR ANTAGONISTS Public/Granted day:2013-01-31
Information query
IPC分类:
